Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:16 AM
Ignite Modification Date:
2025-12-25 @ 3:16 AM
NCT ID:
NCT00954005
Eligibility Criteria:
Inclusion Criteria:
* Need for therapy in patients with relapsed/refractory patients
* Histological proven diagnosis of an indolent B-cell lymphoma according to the World Health Organization (WHO) classification belonging to one of the following entities:
* follicular lymphoma
* mantle cell lymphoma
* lymphoplasmacytic lymphoma
* nodal or splenic marginal zone lymphoma
* measurable disease
* lymphoma specific therapy in the last four weeks
* WHO performance grade 0, 1 or 2
Exclusion Criteria
* Patients suitable for high dose therapy
* Transformation in high grade lymphoma
* Leukocytes \< 1,5/nl or platelets \< 100/nl (except due to lymphoma)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00954005
Study Brief:
Protocol Section:
NCT00954005